InvestorsHub Logo
Followers 31
Posts 3349
Boards Moderated 0
Alias Born 02/09/2017

Re: None

Tuesday, 08/22/2017 1:11:50 PM

Tuesday, August 22, 2017 1:11:50 PM

Post# of 640523
$USRM

Per CEO in last blog "Overall, this summer has been one of great progress and success with many exciting opportunities in the near future. Look for press releases soon on our upcoming clinic openings in Palm Beach and Dallas" , so 2 new clinics opening soon along with Kuwait which is currently under construction. 

Kuwait opening by end of year per 10Q today, 
"The US Stem Cell Clinic in Kuwait is currently under construction and is expected to open before the end of the year" page 25 

Last 5 Quarters say it all, $USRM is building something here. With tides shifting and politics looking favorable I am guessing guidelines from the FDA in September will be even more beneficial to US Stel Cell's mission. 

https://blogs.fda.gov/fdavoice/index.php/2017/07/how-fda-plans-to-help-consumers-capitalize-on-advances-in-science/ ;

ASSETS 
$283k Jun 2016 
$413k Sep 2016 
$427k Dec 2016 
$1385k Mar 2017 
$1632k Jun 2017 

Revenues 
$678k Jun 2016 
$729k Sep 2016 
$964k Dec 2016 
$1154k Mar 2017 
$1386k Jun 2017 (Gross profit now $985k in Jun 2017 vs 443k last Jun 2016) 

Cash and Cash Equivalents 
$130k Jun 2016 
$246k Sep 2016 
$270k Dec 2016 
$619k Mar 2017 
$930k Jun 2017 

336,461,515 shares issued and outstanding as of June 30, 2017 vs 327,613million last quarter. :) 

Also, New Clinical trial completed and added July 20, 2017 

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.